Joanna Boyington, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8000 |
Jade Elizabeth Radigan, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Veronica Krol, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Diane Lilajoyce Janosik, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 215-290-4543 |
Kristi Culp, Physician Assistant Medicare: Medicare Enrolled Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Kydia Ruiz Carrillo, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Shayna J Castagna, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8800 |
Ms. Stacie Madeline Cocke, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 5074 Kernsville Rd, Orefield, PA 18069 Phone: 610-395-1993 Fax: 610-395-2516 |
Chelsea Verros, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 717-679-5934 |
Meghan Primus, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Olivia Kuhn, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1826 Emerald Dr, Orefield, PA 18069 Phone: 610-573-4002 |
Kaitlin Danielle Pubentz, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8800 |
News Archive
A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.
Antares Pharma, Inc. today reported operating and financial results for the fourth quarter and full year ended December 31, 2013.
"Dwindling money for research and development (R&D) and waning donor patience have forced global health players to change how they innovate new products and processes," IRIN reports.
Young adults are increasing their risk for developing skin cancer, according to two studies by the Centers for Disease Control and Prevention and the National Cancer Institute.
› Verified 9 days ago